Skip to main content
. 2022 Oct 30;10(11):1837. doi: 10.3390/vaccines10111837

Figure 1.

Figure 1

Boxplot comparing the COVID-19 anti-spike antibody titre (U/mL) between the participants who received two doses of vaccine at different intervals. The numbers inside the boxplot show the participants who developed antibodies (numerator) and total number of participant (denominator) in each group.